期刊文献+

Role of autophagy in acute myeloid leukemia therapy 被引量:6

Role of autophagy in acute myeloid leukemia therapy
下载PDF
导出
摘要 Despite its dual role in determining cell fate in a wide array of solid cancer cell lines, autophagy has been robustly shown to suppress or kill acute myeloid leukemia cells via degradation of the oncogenic fusion protein that drives leukemogenesis. However, autophagy also induces the demise of acute leukemia cells that do not express the known fusion protein, though the molecular mechanism remains elusive. Nevertheless, since it can induce cooperation with apoptosis and differentiation in response to autophagic signals, autophagy can be manipulated for a better therapy on acute myeloid leukemia. Despite its dual role in determining cell fate in a wide array of solid cancer cell lines, autophagy has been robustly shown to suppress or kill acute myeloid leukemia cells via degradation of the oncogenic fusion protein that drives leukemogenesis. However, autophagy also induces the demise of acute leukemia cells that do not express the known fusion protein, though the molecular mechanism remains elusive. Nevertheless, since it can induce cooperation with apoptosis and differentiation in response to autophagic signals, autophagy can be manipulated for a better therapy on acute myeloid leukemia.
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 2013年第3期130-135,共6页
基金 supported by grants from National Science Foundation of China (No. 31071258) The Ministry of Science and Technology of China (Pre-973 Plan: No. 2011CB512101 863 Plan: No. 2011AA020114) a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
关键词 白血病细胞 髓细胞 自噬 急性 治疗 融合蛋白 肿瘤细胞株 分子机制 Autophagy, fusion oncoprotein, acute myeloid leukemia
  • 相关文献

同被引文献62

  • 1陈新敏,冯文莉,赵世巧,曾建明,白卫君,王小中,黄宗干.HnRNP E2诱骗RNA对白血病K562细胞增殖的影响及其可能机制[J].癌症,2006,25(7):793-797. 被引量:4
  • 2Douglas Hanahan,Robert A. Weinberg.Hallmarks of Cancer: The Next Generation[J]. Cell . 2011 (5)
  • 3Anna M. Eiring,Jason G. Harb,Paolo Neviani,Christopher Garton,Joshua J. Oaks,Riccardo Spizzo,Shujun Liu,Sebastian Schwind,Ramasamy Santhanam,Christopher J. Hickey,Heiko Becker,Jason C. Chandler,Raul Andino,Jorge Cortes,Peter Hokland,Claudia S. Huettner,Ravi Bhatia,Denis C. Roy,Stephen A. Liebhaber,Michael A. Caligiuri,Guido Marcucci,Ramiro Garzon,Carlo M. Croce,George A. Calin,Danilo Perrotti.miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts[J].Cell.2010(5)
  • 4Rebecca L. Siegel,Kimberly D. Miller,Ahmedin Jemal.Cancer statistics, 2015[J]. CA: A Cancer Journal for Clinicians . 2015 (1)
  • 5Corbin, Amie S,Agarwal, Anupriya,Loriaux, Marc,Cortes, Jorge,Deininger, Michael W,Druker, Brian J.Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity[J]. Journal of Clinical Investigation . 2011 (1)
  • 6Pierre Hainaut,Amelie Plymoth.Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapy[J]. Current Opinion in Oncology . 2013 (1)
  • 7Zhi Hong Fang,Chun Lan Dong,Zhong Chen,Bin Zhou,Na Liu,Hai Feng Lan,Lu Liang,Wen Bin Liao,Lei Zhang,Zhong Chao Han.??Transcriptional regulation of survivin by c‐Myc in BCR/ABL‐transformed cells: implications in anti‐leukaemic strategy(J)Journal of Cellular and Molecular Medicine . 2009 (8b)
  • 8Kei-ichi Ozaki,Masaki Kosugi,Nobuyuki Baba,Kohsuke Fujio,Toshiaki Sakamoto,Shinya Kimura,Susumu Tanimura,Michiaki Kohno.??Blockade of the ERK or PI3K–Akt signaling pathway enhances the cytotoxicity of histone deacetylase inhibitors in tumor cells resistant to gefitinib or imatinib(J)Biochemical and Biophysical Research Communications . 2009 (4)
  • 9Krzysztof Mrózek,David P. Harper,Peter D. Aplan.??Cytogenetics and Molecular Genetics of Acute Lymphoblastic Leukemia(J)Hematology/Oncology Clinics of North America . 2009 (5)
  • 10Arinobu Tojo,Kensuke Usuki,Akio Urabe,Yasuhiro Maeda,Yukio Kobayashi,Itsuro Jinnai,Kazuma Ohyashiki,Miki Nishimura,Tatsuya Kawaguchi,Hideo Tanaka,Koichi Miyamura,Yasushi Miyazaki,Timothy Hughes,Susan Branford,Shinichiro Okamoto,Jun Ishikawa,Masaya Okada,Noriko Usui,Hiromi Tanii,Taro Amagasaki,Hiroko Natori,Tomoki Naoe.??A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL(J)International Journal of Hematology . 2009 (5)

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部